Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vir Biotechnology, Inc. - Common Stock
(NQ:
VIR
)
6.120
-0.080 (-1.29%)
Streaming Delayed Price
Updated: 2:24 PM EST, Jan 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vir Biotechnology, Inc. - Common Stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
This Addiction Drug Shows Some Potential Against Long COVID Symptoms
↗
October 19, 2022
Researchers are working on cures for long COVID. With some success, naltrexone has been used to treat pain, fatigue, and brain fog months after a coronavirus infection.
Via
Benzinga
Vir Biotechnology Announces First Patient Dosed in Groundbreaking Phase 2 Trial of VIR-2482 for Antibody Prophylaxis of Influenza A
October 18, 2022
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Vir Biotechnology to Participate in the H. C. Wainwright 3rd Annual Hepatitis B Virus (HBV) Conference
October 11, 2022
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Vir Biotech Secures US Government Contract For Influenza & Other Infectious Disease Candidates
↗
October 04, 2022
Via
Benzinga
This Hepatitis Stock Has 'Multiple Paths To Value Creation,' Expects To Double, Bullish Analyst Predicts
↗
September 14, 2022
Via
Benzinga
Vir Biotech Shuns FDA Submission Plans For GSK-Partnered COVID-19 Treatment
↗
August 10, 2022
Via
Benzinga
Brii Biosciences Exercises Option For Vir Biotechnology's Hepatitis B Antibody In Greater China
↗
July 05, 2022
Via
Benzinga
The Next Pandemic? Vir Biotechnology Just Signed A $1 Billion Deal To Work On It
↗
October 04, 2022
BARDA will pay Vir up to $1 billion to develop its experimental treatment.
Via
Investor's Business Daily
Vir Biotechnology Awarded U.S. Government Contract to Support Pandemic Preparedness for Influenza and Other Infectious Disease Threats
October 04, 2022
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
3 Biotech Stocks to Buy Now for Extraordinary Gains
↗
September 20, 2022
These biotech stocks should deliver big gains to long-term investors who purchase shares at a discount during the bear market.
Via
InvestorPlace
WHO Recommends Against Roche, GSK's COVID-19 Therapies Rendering Them Obsolete
↗
September 16, 2022
Due to the lack of effectiveness against omicron and the variants, World Health Organization (WHO) no longer recommends using two COVID-19 antibody therapies.
Via
Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
↗
September 02, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
↗
September 14, 2022
Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low...
Via
Benzinga
Landmark Drug Pricing Reform Bill Passes Congress House
↗
August 15, 2022
The U.S. House of Representatives voted 220-207 to pass new, wide-ranging legislation allowing Medicare drug price negotiations for the first time and capping seniors’ drug expenses to $2,000 per year...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
↗
September 09, 2022
Upgrades
Via
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
↗
August 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
11 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
August 10, 2022
Gainers
Via
Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
↗
August 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Vir Biotechnology Earnings Preview
↗
August 08, 2022
Vir Biotechnology (NASDAQ:VIR) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that Vir...
Via
Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
↗
August 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For August 9, 2022
↗
August 09, 2022
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
Via
Benzinga
Earnings Preview: Vir Biotechnology
↗
August 03, 2022
Vir Biotechnology (NASDAQ:VIR) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Vir...
Via
Benzinga
7 Undervalued Biotech Stocks to Buy Before They Boom
↗
July 25, 2022
Despite recession fears, biological sciences will never go out of style, thus benefitting these undervalued biotech stocks to buy.
Via
InvestorPlace
Vir Biotechnology Stock Joins Rank Of Stocks With RS Ratings Over 90
↗
July 11, 2022
On Monday, Vir Biotechnology stock had its Relative Strength (RS) Rating upgraded to 91 Monday, up from 85 a day earlier.
Via
Investor's Business Daily
Is Merck Stock A Buy Amid Reports It Could Buy Seagen For $40 Billion?
↗
July 07, 2022
Is Merck stock a buy as reports suggest it could put up $40 billion to acquire Seagen? Is MRK stock a buy right now?
Via
Investor's Business Daily
From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid
↗
June 27, 2022
More than four in 10 people in a recent survey knew of someone with long Covid.
Via
Investor's Business Daily
Billionaire Bill Gates Is Betting Against TSLA Stock. Here’s Where He’s Putting His Money Instead.
↗
May 25, 2022
Earlier this year, it was revealed that Bill Gates had a half a billion dollar short position against TSLA stock. So, what is he bullish on?
Via
InvestorPlace
HC Wainwright Says This Stock Is Well Capitalized For Value Realization Of Pipeline, Despite COVID-19 Uncertainty
↗
May 12, 2022
Via
Benzinga
10 Biggest Price Target Changes For Thursday
↗
May 12, 2022
Wells Fargo cut the price target on Ford Motor Company (NYSE: F) from $24 to $12. Ford shares fell 2.8% to $12.47 in pre-market trading.
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
↗
May 09, 2022
What Defines a Value Stock?
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
